AMRX Short-Term Debt
Amneal Pharmaceuticals Inc Class A · Short-Term Debt
AMRX Short-Term Debt
Latest reported$21.58Mperiod ending
AMRX FY Short-Term Debt ($59.69M → $21.58M)
Annual short-term debt
High-resolution chart · PNG
AMRX short-term debt history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Short-Term Debt (USD) |
|---|---|
| 21,576,000 | |
| 340,255,000 | |
| 227,624,000 | |
| 104,639,000 | |
| 46,037,000 | |
| 57,474,000 | |
| 36,954,000 | |
| 21,715,000 | |
| 89,482,000 | |
| 36,985,000 | |
| 59,686,000 |